心臟植入市场规模、份额和增长分析（按设备类型、应用、最终用户和地区）- 行业预测，2025 年至 2032 年

全球心臟植入市场预计将在 2023 年达到 161 亿美元，并从 2024 年的 171.1 亿美元增长到 2032 年的 279 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.3%。

由于心血管疾病发病率上升、技术进步和人口老化，全球心臟植入市场正在经历强劲增长。久坐的生活方式和肥胖、糖尿病等健康问题日益严重，推动了对心臟植入的需求，心臟植入物被认为是改善患者生活品质的重要治疗选择。小型化和无线连接等技术进步使得心律调节器和心臟去颤器等设备更加高效且更易于使用。然而，市场面临的挑战包括高成本限制了低收入地区的可用性，严格的监管障碍减缓了新产品的推出，以及对长期性能和潜在併发症的担忧。应对这些挑战对于促进心臟植入领域的创新和确保病患安全至关重要。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术进步

心臟植入市场规模（按设备类型和复合年增长率） (2025-2032)

• 市场概况
• 心律调节器装置
• 心臟再同步治疗装置
• 植入式血流动力学监测装置
• 植入式心率监测仪
• 冠状动脉支架
• 植入式心臟整流去颤器
• 心臟瓣膜
• 其他的

心臟植入市场规模（按应用划分）及复合年增长率（2025-2032）

• 市场概况
• 心律不整
• 心肌缺血
• 急性心肌梗塞
• 郁血性心臟衰竭
• 其他的

心臟植入市场规模（按最终用户和复合年增长率划分）（2025-2032）

• 市场概况
• 医院
• 专科门诊
• 其他的

心臟植入市场规模（按地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Medtronic（USA）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Biotronik SE & Co. KG（Germany）
• Lepu Medical Technology Co., Ltd.（China）
• LivaNova PLC（UK）
• Osypka AG（Germany）
• Oscor Inc.（USA）
• Pacetronix（India）
• Medico SpA（Italy）
• MicroPort Scientific Corporation（China）
• Shree Pacetronix Ltd.（India）
• Biotricity Inc.（USA）
• Cardiac Science Corporation（USA）
• EBR Systems, Inc.（USA）
• Jarvik Heart, Inc.（USA）
• Berlin Heart GmbH（Germany）
• ReliantHeart Inc.（USA）
• SynCardia Systems, LLC（USA）
• BiVacor（USA）

结论和建议

Global Cardiac Implants Market size was valued at USD 16.1 billion in 2023 and is poised to grow from USD 17.11 billion in 2024 to USD 27.9 billion by 2032, growing at a CAGR of 6.3% during the forecast period (2025-2032).

The global cardiac implants market is experiencing robust growth, propelled by the rising prevalence of cardiovascular diseases, technological innovations, and an aging demographic. Increasing sedentary lifestyles and health issues, such as obesity and diabetes, are heightening the demand for cardiac implants, which are viewed as vital treatment options to enhance patient quality of life. Technological advancements, including miniaturization and wireless connectivity, are improving the efficiency and user-friendliness of devices like pacemakers and defibrillators. However, the market faces challenges, including high costs that limit accessibility in low-income areas, stringent regulatory hurdles that can delay new product introduction, and concerns regarding long-term performance and potential complications. Addressing these challenges is essential for fostering innovation and ensuring patient safety in the cardiac implants sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Implants market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Implants Market Segmental Analysis

Global Cardiac Implants Market is segmented by Device Type, Application, End User and region. Based on Device Type, the market is segmented into Pacemaker Devices, Cardiac Resynchronization Therapy Devices, Implantable Hemodynamic Monitoring Devices, Implanted Heart Rhythm Monitors, Coronary Stents, Implantable Cardioverter Defibrillator, Heart Valve and Others. Based on Application, the market is segmented into Arrhythmias, Myocardial Ischemia, Acute Myocardial Infraction, Congestive Heart Failure and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Implants Market

One of the key factors propelling the global cardiac implants market is the escalating incidence of cardiovascular diseases, encompassing conditions such as heart failure, arrhythmias, and coronary artery disease. This rise can be attributed to various contributors, including increasingly sedentary lifestyles, poor dietary choices, and a rapidly aging population. As these factors lead to a greater prevalence of cardiovascular issues, the demand for cardiac implants intensifies, thereby driving market growth. The urgent need for effective treatment options to manage these conditions highlights the significance of the cardiac implants sector in addressing the healthcare challenges posed by cardiovascular diseases.

Restraints in the Global Cardiac Implants Market

One of the significant challenges facing the global cardiac implants market is the rigorous regulatory approval processes that manufacturers must navigate. Compliance with the stringent standards set by regulatory authorities, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), can often be a lengthy and expensive undertaking. This extensive vetting process can result in delays for the launch of new technologies and products, hindering innovation and stifling the overall growth of the market. As a result, these regulatory hurdles create a restrictive environment for the advancement of cardiac implant solutions.

Market Trends of the Global Cardiac Implants Market

The Global Cardiac Implants market is experiencing a notable shift towards the integration of remote monitoring and digital health solutions, reflecting a burgeoning trend in patient care. This innovation facilitates continuous oversight of patients' cardiac health and device functionality, empowering healthcare providers to deliver prompt interventions and tailored treatment plans. By leveraging these technologies, the market is not only enhancing patient management but also significantly reducing hospital readmissions, thereby improving overall healthcare efficiency. As patient-centered care gains prominence, the adoption of remote monitoring solutions is poised to reshape the cardiac implants landscape, driving growth and innovation within the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Cardiac Implants Market Size by Device Type & CAGR (2025-2032)

• Market Overview
• Pacemaker Devices
• Cardiac Resynchronization Therapy Devices
• Implantable Hemodynamic Monitoring Devices
• Implanted Heart Rhythm Monitors
• Coronary Stents
• Implantable Cardioverter Defibrillator
• Heart Valve
• Others

Global Cardiac Implants Market Size by Application & CAGR (2025-2032)

• Market Overview
• Arrhythmias
• Myocardial Ischemia
• Acute Myocardial Infraction
• Congestive Heart Failure
• Others

Global Cardiac Implants Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Specialty Clinics
• Others

Global Cardiac Implants Market Size & CAGR (2025-2032)

• North America (Device Type, Application, End User)
  • US
  • Canada
• Europe (Device Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Device Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Device Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Device Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Osypka AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oscor Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacetronix (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medico S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shree Pacetronix Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotricity Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiac Science Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EBR Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jarvik Heart, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berlin Heart GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReliantHeart Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SynCardia Systems, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BiVacor (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations